Product Information
MIRABEGRON ER 25 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $9.1767 per EA under NDC 70710115903. Its NADAC has been published 116 times since Jul 17, 2024.
FDA first approved this application on Sep 29, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710115903
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MIRABEGRONApproval Type
Generic (ANDA)
FDA Application
ANDA209488FDA Approved
9/29/2022
TE Code
AB
On Market Since
1/23/2024
Pharmacological Classes
Price Statistics
The NADAC for MIRABEGRON ER 25 MG TABLET has been published 116 times since Jul 17, 2024, and over the history we have for it it has risen 13.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.1767 per EA |
|---|---|
| All-time high | $10.9668 (Sep 11, 2024) |
| All-time low | $8.0956 (Jul 17, 2024) |
| 52-week high | $10.1389 |
| 52-week low | $9.1767 |
| Median price | $9.8874 |
| Average price | $9.7914 |
| Largest weekly change | +35.5% (Aug 21, 2024) |
| Weeks tracked | 116 |
| Tracking since | Jul 17, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Mirabegron market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta3-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MIRABEGRON ER 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MIRABEGRON ER 25 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $9.1767 per EA (NDC 70710115903), effective Sep 30, 2026.
How has the price of MIRABEGRON ER 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for MIRABEGRON ER 25 MG TABLET has risen 13.4%. It has been tracked across 116 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for MIRABEGRON ER 25 MG TABLET?
Since Jul 17, 2024, the NADAC for MIRABEGRON ER 25 MG TABLET has ranged from a low of $8.0956 (Jul 17, 2024) to a high of $10.9668 (Sep 11, 2024), with a median of $9.8874 per EA.
Are there cheaper alternatives to MIRABEGRON ER 25 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MIRABEGRON ER 25 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MIRABEGRON ER 25 MG TABLET?
MIRABEGRON ER 25 MG TABLET (NDC 70710115903) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.